Insulin inhibits platelet-derived growth factor-induced cell proliferation

Molecular Biology of the Cell

Volumn 16, Issue 1, 2005, Pages 73-83

  Cirri, P ^a   Taddei, M L ^a   Chiarugi, P ^a   Buricchi, F ^a   Caselli, A ^a   Paoli, P ^a   Giannoni, E ^a   Camici, G ^a   Manao, G ^a   Raugei, G ^a   Ramponi, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HYDROGEN PEROXIDE; INSULIN; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MITOGENESIS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CELL COMMUNICATION; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; ENDOCYTOSIS; GENTIAN VIOLET; HYDROGEN PEROXIDE; IMMUNOPRECIPITATION; INSULIN; MICE; MITOSIS; NIH 3T3 CELLS; OXIDATION-REDUCTION; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; REACTIVE OXYGEN SPECIES; RECEPTOR, INSULIN; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SRC-FAMILY KINASES; THYMIDINE; TIME FACTORS; TYROSINE;

ANIMALIA;

EID: 19944407085     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-01-0011     Document Type: Article

References (40)

1. Bae, Y. S., Kang, S. W., Seo, M. S., Baines, I. C., Tekle, E., Chock, P. B., and Rhee, S. G. (1997). Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221.
2. Bae, Y. S., Sung, J. Y., Kim, O. S., Kim, Y. J., Hur, K. C., Kazlauskas, A., and Rhee, S. G. (2000). Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275, 10527-10531.
3. Burridge, K. and Nelson, A. (1995). An in-gel assay for protein tyrosine phosphatase activity: detection of widespread distribution in cells and tissue. Anal. Biochem. 232, 56-64.
4. Ceresa, B. P., Kao, A. W., Santeler, S. R., and Pessin, J. E. (1998). Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol. Cell Biol. 18, 3862-3870.
5. Chiarugi, P., Cirri, P., Marra, F., Raugei, G., Camici, G., Manao, G., and Ramponi, G. (1997). LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling. Biochem. Biophys. Res. Commun. 238, 676-682.
6. Chiarugi, P., Cirri, P., Raugei, G., Camici, G., Dolfi, F., Berti, A., and Ramponi, G. (1995). platelet-derived growth factor receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett. 372, 49-53.
7. Giannoni, E., Camici, G., Raugei, G., and Ramponi, G. (2002). New perspectives in platelet-derived growth factor receptor downregulation: the main role of phosphotyrosine phosphatases. J. Cell Sci. 115, 2219-2232.
8. Chiarugi, P., Fiaschi, T., Taddei, M. L., Talini, D., Giannoni, E., Raugei, G., and Ramponi, G. (2001). Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J. Biol. Chem. 276, 33478-33487.
9. Choudhury, G. G., Wang, L. M., Pierce, J., Harvey, S. A., and Sakaguchi, A. Y. (1991). A mutational analysis of phosphatidylinositol-3-kinase activation by human colony-stimulating factor-1 receptor. J. Biol. Chem. 266, 8068-8072.
10. Claesson-Welsh, L., Eriksson, A., Westermark, B., and Heldin, C. H. (1989). cDNA cloning and expression of the human A-type platelet-derived growth factor receptor establishes structural similarity to the B-type platelet-derived growth factor receptor. Proc. Natl. Acad. Sci. USA 86, 4917-4921.
11. Heldin, C. H., and Westermark, B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316.
12. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
13. Jacobson, M. D. (1996). Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21, 83-86.
14. Jiang, G., and Hunter, T. (1999). Receptor signaling: when dimerization is not enough. Curr. Biol. 9, R568-R571.
15. Kamata, H., and Hirata, H. (1999). Redox regulation of cellular signalling. Cell Signal. 11, 1-14.
16. Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y., Kikkawa, U., and Nishizuka, Y. (1997). Activation of PKC by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. USA 94, 11233-11237.
17. Lee, S. R., Kwon, K. S., Kim, S. R., and Rhee, S. G. (1998). Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with EGF. J. Biol. Chem. 273, 15366-15372.
18. Lemmon, M. A., and Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19, 459-463.
19. Levy-Toledano, R., Blaettler, D. H., LaRochelle, W. J., and Taylor, S. I. (1995). Insulin-induced activation of phosphatidylinositol (PI) 3-kinase. Insulin-induced phosphorylation of insulin receptors and insulin receptor substrate-1 displaces phosphorylated platelet-derived growth factor receptors from binding sites on PI 3-kinase. J. Biol. Chem. 270, 30018-30022.
20. Liu, F., and Roth, R. A. (1998). Binding of SH2 containing proteins to the insulin receptor: a new way for modulating insulin signalling. Mol. Cell Biochem. 182, 73-78.
21. Meng, T. C., Fukada, T., and Tonks, N. K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387-399.
22. Min, D. S., Kim, E. G., and Exton, J. H. (1998). Involvement of tyrosine phosphorylation and PKC in the activation of phospholipase D by H2O2 in Swiss 3T3 fibroblasts. J. Biol. Chem. 273, 29986-29994.
23. Mori, S., Heldin, C. H., and Claesson-Welsh, L. (1992). Ligand-induced polyubiquitination of the platelet-derived growth factor beta-receptor. J. Biol. Chem. 267, 6429-6434.
24. Mori, S., Heldin, C. H., and Claesson-Welsh, L. (1993). Ligand-induced ubiquitination of the platelet-derived growth factor beta-receptor plays a negative regulatory role in its mitogenic signaling. J. Biol. Chem. 268, 577-583.
25. Mori, S., Tanaka, K., Omura, S., and Saito, Y. (1995). Degradation process of ligand-stimulated platelet-derived growth factor beta-receptor involves ubiquitin-proteasome proteolytic pathway. J. Biol. Chem. 270, 29447-29452.
26. Ogawa, W., Matozaki, T., and Kasuga, M. (1998). Role of binding proteins to IRS-1 in insulin signalling. Mol. Cell Biochem. 182, 13-22.
27. Ostman, A., and Bohmer, F. D. (2001). Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 11, 258-266.
28. Pahl, H. L., and Baeuerle, P. A. (1994). Oxygen and the control of gene expression. Bioessays 16, 497-502.
29. Pronk, G. J., McGlade, J., Pelicci, G., Pawson, T., and Bos, J. L. (1993). Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268, 5748-5753.
30. Schlessinger, J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
31. Schreck, R., Rieber, P., and Baeuerle, P. A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10, 2247-2258.
32. Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J., Jr., Backer, J. M., Ullrich, A., and White, M. F. (1993). The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12, 1929-1936.
33. Sorkin, A., Westermark, B., Heldin, C. H., and Claesson-Welsh, L. (1991). Effect of receptor kinase inactivation on the rate of internalization and degradation of platelet-derived growth factor and the platelet-derived growth factor beta-receptor. J. Cell Biol. 112, 469-478.
34. Staubs, P. A., Nelson, J. G., Reichart, D. R., and Olefsky, J. M. (1998). Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J. Biol. Chem. 273, 25139-25147.
35. Sun, X. J., Crimmins, D. L., Myers, M. G., Jr., Miralpeix, M., and White, M. F. (1993). Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell Biol. 13, 7418-7428.
36. Sundaresan, M., Yu, Z. X., Ferrans, V. J., Irani, K., and Finkel, T. (1995). Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
37. Tobe, K., et al. (1996). Csk enhances insulin-stimulated dephosphorylation of focal adhesion proteins. Mol. Cell Biol. 16, 4765-4772.
38. Wang, J., Dai, H., Yousaf, N., Moussaif, M., Deng, Y., Boufelliga, A., Swamy, O. R., Leone, M. E., and Riedel, H. (1999). Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis. Mol. Cell Biol. 19, 6217-6228.
39. White, M. F. (1998). The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog. Horm. Res. 53, 119-138.
40. Zor, U., Ferber, E., Gergely, P., Szucs, K., Dombradi, V., and Goldman, R. (1993). Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate. Biochem. J. 295, 879-888.